Profiles

Keywords
Last Name
Institution

Connection

John Somberg to Tachycardia

This is a "connection" page, showing publications John Somberg has written about Tachycardia.

 
Connection Strength
 
 
 
2.883
 
  1. Somberg J, Molnar J. The dark side of implantable cardioverter defibrillator therapy. Cardiology. 2013; 124(4):213-5.
    View in: PubMed
    Score: 0.601
  2. Somberg JC. Usefulness of electrophysiologic studies in predicting drug efficacy in patients receiving amiodarone. Am J Cardiol. 1987 Nov 15; 60(14):1218.
    View in: PubMed
    Score: 0.104
  3. Somberg JC, Tepper D, Sacher H, Schwarz J. Chronic flecainide therapy selected by electrophysiology testing of intravenous flecainide. Am Heart J. 1987 Jul; 114(1 Pt 1):18-25.
    View in: PubMed
    Score: 0.101
  4. Miura DS, Schwartz J, Laux B, Wynn J, Keefe D, Somberg JC. Comparative efficacy of pirmenol and procainamide in a drug-resistant population with ventricular tachycardia. J Clin Pharmacol. 1987 Jul; 27(7):481-6.
    View in: PubMed
    Score: 0.101
  5. Wynn J, Fingerhood M, Keefe D, Maza S, Miura D, Somberg JC. Refractory ventricular tachycardia with flecainide. Am Heart J. 1986 Jul; 112(1):174-5.
    View in: PubMed
    Score: 0.094
  6. Keefe DL, Miura D, Somberg JC. Supraventricular tachyarrhythmias: their evaluation and therapy. Am Heart J. 1986 Jun; 111(6):1150-61.
    View in: PubMed
    Score: 0.094
  7. Miura DS, Wynn J, Torres V, Laux B, Keefe D, Somberg JC. Antiarrhythmic efficacy of ethmozine in patients with ventricular tachycardia as determined by programmed electrical stimulation. Am Heart J. 1986 Apr; 111(4):661-6.
    View in: PubMed
    Score: 0.093
  8. Wynn J, Miura DS, Torres V, Flowers D, Keefe D, Williams S, Somberg JC. Electrophysiologic evaluation of the antiarrhythmic effects of N-acetylprocainamide for ventricular tachycardia secondary to coronary artery disease. Am J Cardiol. 1985 Nov 15; 56(13):877-81.
    View in: PubMed
    Score: 0.090
  9. Torres V, Flowers D, Somberg J. The clinical significance of polymorphic ventricular tachycardia provoked at electrophysiologic testing. Am Heart J. 1985 Jul; 110(1 Pt 1):17-24.
    View in: PubMed
    Score: 0.088
  10. Miura DS, Keren G, Torres V, Butler B, Aogaichi K, Somberg JC. Antiarrhythmic effects of cibenzoline. Am Heart J. 1985 Apr; 109(4):827-33.
    View in: PubMed
    Score: 0.087
  11. Somberg JC, Butler B, Torres V, Tepper D, Keren G, Siegel L, Jentzer J, Miura DS. Therapy for late post infarction ventricular tachycardia. Angiology. 1985 Mar; 36(3):181-90.
    View in: PubMed
    Score: 0.086
  12. Somberg J, Torres V, Flowers D, Miura D, Butler B, Gottlieb S. Prolongation of QT interval and antiarrhythmic action of bepridil. Am Heart J. 1985 Jan; 109(1):19-27.
    View in: PubMed
    Score: 0.085
  13. Somberg J, Butler B, Flowers D, Tepper D, Torres V. Long term lorcainide therapy guided by electrophysiology studies. Acta Cardiol. 1985; 40(6):621-36.
    View in: PubMed
    Score: 0.085
  14. Somberg J, Butler B, Flowers D, Keefe D, Torres V, Miura D. Long-term lorcainide therapy in patients with ventricular tachycardia. Am Heart J. 1985 Jan; 109(1):33-40.
    View in: PubMed
    Score: 0.085
  15. Flowers D, O'Gallagher D, Torres V, Miura D, Somberg JC. Flecainide: long-term treatment using a reduced dosing schedule. Am J Cardiol. 1985 Jan 01; 55(1):79-83.
    View in: PubMed
    Score: 0.085
  16. Torres V, Flowers D, Miura D, Somberg J. Intravenous quinidine by intermittent bolus for electrophysiologic studies in patients with ventricular tachycardia. Am Heart J. 1984 Dec; 108(6):1437-42.
    View in: PubMed
    Score: 0.085
  17. Keren G, Tepper D, Butler B, Torres V, Somberg JC. The effect of bepridil, verapamil, and quinidine in the prevention of ventricular tachycardia induced by programmed electrical stimulation in the digitalized dog. Am Heart J. 1984 Nov; 108(5):1236-43.
    View in: PubMed
    Score: 0.084
  18. Keren G, Tepper D, Butler B, Miura D, Aogaichi K, Somberg J. The efficacy of cibenzoline in preventing PES induction of ventricular tachycardia in the dog. J Clin Pharmacol. 1984 Oct; 24(10):466-72.
    View in: PubMed
    Score: 0.084
  19. Somberg JC. New directions in antiarrhythmic drug therapy. Am J Cardiol. 1984 Aug 13; 54(4):8B-17B.
    View in: PubMed
    Score: 0.083
  20. Somberg JC, Butler B, Torres V, Flowers D, Tepper D, Keefe D, Miura DS. Lorcainide therapy for the high-risk patient post myocardial infarction. Am J Cardiol. 1984 Aug 13; 54(4):37B-42B.
    View in: PubMed
    Score: 0.083
  21. Somberg JC, Butler B, Flowers D, Keefe D, Torres V, Miura D. Evaluation of lorcainide in patients with symptomatic ventricular tachycardia. Am J Cardiol. 1984 Aug 13; 54(4):43B-48B.
    View in: PubMed
    Score: 0.083
  22. Somberg JC, Butler B, Flowers D, Tepper D, Maguire W, Willens H, Keren G, Miura D. Comparison of noninvasive arrhythmia induction techniques with electrophysiologic studies and evaluation of lorcainide in patients with symptomatic ventricular tachycardia. Am J Cardiol. 1984 Aug 13; 54(4):49B-54B.
    View in: PubMed
    Score: 0.083
  23. Somberg JC, Butler B, Torres V, Flowers D, Tepper D, Wynn J, Keren G, Miura DS. Antiarrhythmic action of bethanidine. Am J Cardiol. 1984 Aug 01; 54(3):343-6.
    View in: PubMed
    Score: 0.083
  24. Keren G, Miura DS, Somberg JC. Pacing termination of ventricular tachycardia: influence of antiarrhythmic-slowed ectopic rate. Am Heart J. 1984 Apr; 107(4):638-43.
    View in: PubMed
    Score: 0.081
  25. Spivack C, Gottlieb S, Miura DS, Somberg JC. Flecainide toxicity. Am J Cardiol. 1984 Jan 15; 53(2):329-30.
    View in: PubMed
    Score: 0.080
  26. Somberg J, Kreamer J, Camba N. Amiodarone therapy guided by electrophysiologic testing: an update. J Clin Pharmacol. 1991 Nov; 31(11):1089-95.
    View in: PubMed
    Score: 0.034
  27. Wyndham CR, Pratt CM, Mann DE, Winkle RA, Somberg J, de Maria AN, Josephson ME. Electrophysiology of Ethmozine (moricizine HCl) for ventricular tachycardia. Am J Cardiol. 1987 Oct 16; 60(11):67F-72F.
    View in: PubMed
    Score: 0.026
  28. Schwartz J, Crocker K, Wynn J, Somberg JC. The antiarrhythmic effects of d-sotalol. Am Heart J. 1987 Sep; 114(3):539-44.
    View in: PubMed
    Score: 0.026
  29. Somberg JC, Miura D, Keefe DL. The treatment of ventricular rhythm disturbances. Am Heart J. 1986 Jun; 111(6):1162-76.
    View in: PubMed
    Score: 0.023
  30. Torres V, Tepper D, Flowers D, Wynn J, Lam S, Keefe D, Miura DS, Somberg JC. QT prolongation and the antiarrhythmic efficacy of amiodarone. J Am Coll Cardiol. 1986 Jan; 7(1):142-7.
    View in: PubMed
    Score: 0.023
  31. Somberg J, Tepper D, Wynn J. Prolonged repolarization: a historical perspective. Am Heart J. 1985 Feb; 109(2):395-8.
    View in: PubMed
    Score: 0.021
  32. Somberg JC. New approaches to drug selection and serial drug testing. J Clin Pharmacol. 1984 Jul; 24(7):320-7.
    View in: PubMed
    Score: 0.021
  33. Cagin NA, Somberg J, Bounous H, Mittag T, Raines A, Levitt B. The influence of spinal cord transection on the capacity of digitoxin to induce cardiotoxicity. Arch Int Pharmacodyn Ther. 1974 Feb; 207(2):340-7.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.